
23 ASX share ideas for your 2023 watchlist
Get some top ASX share ideas for 2023. Wesfarmers Ltd
Rask Media > CSL Limited (ASX:CSL) > Page 11
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Get some top ASX share ideas for 2023. Wesfarmers Ltd
The CSL Limited (ASX:CSL) share price is down after it
Danielle Ecuyer of Shareplicity joins Owen Rask and Kate Campbell
The S&P/ASX 200 (INDEXASX: XJO) managed a small gain on
The CSL Limited (ASX: CSL) share price is in focus
Nathan Bell, CFA is Head of Portfolio Management at The
Drew Meredith, CFP and Owen Rask are back on The
The CSL Limited (ASX:CSL) share price is in focus after
The S&P/ASX 200 (NDEXASX:XJO) price bounced on Tuesday, with the
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.